Please read carefully re Bioamber warrants, section 9. (D) "The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor The "Successor Entity" to assume in writing all the obligations of the Company's warrants and other transaction documents, also (go to the end of this long filing and you will find the word ACTIVE) https://www.sec.gov/Archives/edgar/data/1534287/000156459017000686/bioa-ex41_7.htm